Source Health Economics
  • Home
  • Services
    • Economic Modelling & Data Analysis
    • Evidence Generation
    • Market Access and Value Communication
    • Health Technology Assessment
    • Training
  • Team
  • Insights
  • Join us
  • Get in touch
Select Page
NICE tests a new approach for evaluating and reimbursing antimicrobials

NICE tests a new approach for evaluating and reimbursing antimicrobials

by Rachel Montague | May 26, 2022 | Industry insights

Written by Chris Hellmund, Senior Medical Writer Antimicrobial resistance is a major threat to global health that threatens to reverse the progress of modern medicine. More infections are becoming harder to treat, and without coordinated efforts we face a future in...
A quick look at network meta-analyses for National Numeracy Day!

A quick look at network meta-analyses for National Numeracy Day!

by Rachel Montague | May 18, 2022 | Industry insights

Written by Abby Paine, Statistician It’s National Numeracy Day, which is run by National Numeracy, a charity that aims to enable everyone across the UK to be confident and competent in using numbers and data. This is such an important issue; you may not realise it,...
Limiting conference abstract searching for systematic reviews

Limiting conference abstract searching for systematic reviews

by Rachel Montague | May 17, 2022 | Industry insights

Written by Isobel Munro, Associate Systematic Review Analyst The purpose of conducting a systematic literature review (SLR) is to identify a complete and unbiased set of studies relevant to the proposed research question. However, it is not only studies that have been...
Moving from academia to consultancy, is it for you?

Moving from academia to consultancy, is it for you?

by Rachel Montague | Apr 27, 2022 | Source news

Written by Alec Miners, Head of Health Economics Contemplating ‘change’ of any kind can be daunting. Choosing a new career direction is no exception. I joined Source Health Economics as Head of Health Economics in March this year after 16 years in academia and 5 years...
ILAP breakdown for UK HTAs and market access

ILAP breakdown for UK HTAs and market access

by Rachel Montague | Apr 14, 2022 | Industry insights

Written by Luke Parkes, Assistant Project Manager ILAP remit  It has been just over a year since the Medicines and Healthcare Products Regulatory Agency (MHRA) established the Innovative Licensing and Access Pathway (ILAP) in response to Britain’s exit from the...
« Older Entries
Next Entries »

London

7th Floor, North Building
1 Triptych Place, London SE1 9SH, UK

Oxford

Floor 2, 226 Banbury Road, Summertown, Oxford, OX2 7BY
+44 (0) 1865 920 567

Connect

Connect with us on LinkedIn

  • © Source Market Access Ltd t/a Source Health Economics
  • Cookies
  • Website by Herd

Company registration number: 10284529 | VAT number: GB248 0293 06

Cookies Policy

Our Website uses cookies to improve your experience. Please visit our Cookies page for more information about cookies and how we use them.

Close